The Value of High-Sensitivity Troponin in the Era of COVID-19

Studies have shown that patient with COVID-19 and underlying Cardiovascular disease were more likely to show raised cardiac Troponin-T and have a 70% risk of poor prognosis or early mortality, further data suggest that level of cardio biomarkers like myoglobin, NT-pro BNP was significantly higher in severe & critical cases versus mild cases. It was known that in Covid infections, cardiac morbidities like Myocarditis, Hypertensive crisis, CHF, and Myocardial infarction can cause marked elevation of Troponin T. Thus it is can be concluded that Level of Troponin-T can help us in risk stratification, prognostication, and categorization of Covid cases. In March 2020, the European Society of Cardiology and American College of Cardiology has recommended measuring cTnT only if the diagnosis of MI is being considered on clinical grounds or if there is new onset of LV dysfunction. Disclaimer: Lupin makes no representation or warranty of any kind, expressed or implied, regarding the accuracy, adequacy, validity, reliability, availability or completeness of any scientific information shared by the HCP on the ­­­STAR UPDATE podcast. You should not allow the contents of this to substitute for your own medical judgment, which you should exercise in evaluating the information on this website.